The Supreme Court maintained access to the abortion pill mifepristone, unanimously refusing to hear a case brought by a number of anti-abortion organizations and doctors over the Food and Drug Administration’s (FDA) approval of the pill.
“The plaintiffs have sincere legal, moral, ideological, and policy objections to elective abortion and to FDA’s relaxed regulation of mifepristone,” Justice Brett Kavanaugh wrote in the majority opinion issued Thursday. “But under Article III of the Constitution, those kinds of objections alone do not establish a justiciable case or controversy in federal court.”
In 2022 — after the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, the ruling that overturned Roe v. Wade — a newly…
Continue reading…
